학술논문
EZHIP is a specific diagnostic biomarker for posterior fossa ependymomas, group PFA and diffuse midline gliomas H3-WT with EZHIP overexpression
Document Type
article
Author
Source
Acta Neuropathologica Communications, Vol 8, Iss 1, Pp 1-5 (2020)
Subject
Language
English
ISSN
2051-5960